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It has been suggested that the transmission of skin-sensitizing antibodies from the 
maternal to the fetal circulation may be a factor in the development of allergic diseases. 
Certain  other  antibodies  such  as  diphtheria  antitoxin,  typhoid  agglutinin,  tetanus 
antitoxin, hemolysins, and bacteriolysins, have been shown to pass through the human 
placenta from mother to fetus.  Excellent reviews of this subject have been published 
by Ratner, Jackson, and Gruehl (1), Bell and Erickkson (2), Lippard and Wheeler (3), 
and Wiener and  Silverman  (4)  and  others.  Placental transmission of antibodies re- 
sponsible for anaphylactic shock has been demonstrated in the lower animals by Rosenau 
and Anderson (5), Otto (6), Wells (7), Schenck (8), Lewis (9), Ratner and his coworkers 
(10),  and  Cohen  and Woodruff (11).  Cohen,  Cohen,  and Hawver  (12)  reported the 
presence of skin-sensitlzing antibodies in the blood of a  newborn rhesus monkey after 
injection of a sensitive human serum into the mother within 7 days prior to delivery. 
Placental transmission of skin-sensitizing antibodies in the human being has not been 
shown.  Bell and  Erickkson  (2)  were  unable  to  demonstrate in  the  cord sera of  10 
allergic mothers  the skin-sensitizing antibodies that were shown  to be present in  the 
maternal sera in various dilutions.  Caulfeild (13) also reported inability to demonstrate 
skin-sensitizing antibodies in  the  cord  sera of  2  allergic mothers.  Walzer  (14)  in  a 
discussion of Bell's paper supported Bell's findings.  Zohn (15) was unable to show such 
antibodies in the cord blood of 11 women actively sensitized and skin-reactive to Ascaris 
lumbricoides, although  the maternal blood of 9  of the women was positive by passive 
transfer tests. 
Wiener and Silverman (4), on the basis of titratiorr of the hemagglutinin content of 
maternal and cord blood, reported that "the index of permeability of the human placenta 
to antibodies or the coefficient of distribution of antibodies between maternal and cord 
blood" falls between 8 and 16.  They suggested that the failure to detect placental trans- 
mission of skin-sensitizing  antibody was due to the small amounts present in the maternal 
blood and lack of quantitative studies thereof. 
Although all  the direct evidence has shown  there is no  transmission  of 
skin-sensitizing  antibodies  through  the  human  placenta,  the  apparently 
contradictory evidence  of transmission  of other human  antibodies and of 
certain  anaphylactic  antibodies in experimental animals has  caused many 
to doubt that the point was completely proved.  Therefore, it seems worth 
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while  to  report  quantitative  studies  confirming  the  findings  of  Bell and 
Erickkson. 
In  the present investigation,  observations have  also been made on the 
transmission  from the mother to the fetus of the "blocking" or "immune" 
antibody which is present in the  serum of hay fever patients  after  treat- 
ment with injections of pollen extract.  The presence of such an antibody, 
distinct  from  the  skin-sensitizing  antibody,  was  suggested  by  Cooke, 
Barnard,  Hebald,  and  Stull  (16).  Further  evidence of its  existence  was 
given by Loveless (17),  who demonstrated  that  the  skin-sensitizing  anti- 
body was destroyed by heat, while the new antibody produced in response 
to treatment was not destroyed. 
Titration of Skin-Sensitizing Antibody 
Twelve sera from allergic pregnant women, drawn during the latter half 
of pregnancy, were shown to contain skin-sensitizing antibodies to various 
antigens.  At the time of delivery, blood was obtained from the umbilical 
cord  using  sterile  precautions.  In  six  cases,  samples  of  colostrum  were 
also obtained.  The  sera were separated  from  the  clotted bloods, passed 
through  Seitz filters, proved sterile  by culture,  and  Kline  tests were per- 
formed.  Passive transfer studies were carried out in the skin of test sub- 
jects  non-reactive  to  those  aliergen  extracts  tested.  The  corresponding 
maternal  serum,  cord serum,  and colostrum were studied in the same test 
subject.  Skin sites were prepared with 0.1 cc. of concentrated  serum and 
its  dilutions  1-10,  1-100,  1-1000,  and  1-10,000  in  saline,  and  tested  48 
hours  later  with  0.025  cc.  of  allergen  extract  containing  1000  protein 
nitrogen units t per cc. 
Each of the maternal  sera reacted in passive transfer  sites with  one or 
more allergen extracts, including ragweed, timothy, plantain, sorrel, ash, and 
birch pollen, cottonseed, kapok, dust, wheat, dog and horse dander  (Table 
I).  Ten of the 12 sera were positive in a dilution of 1-100 and 3 sera were 
still positive in a dilution of 1-1000.  The 12 corresponding cord sera were 
tested  with  the  same  antigens  but  none  gave  positive  passive  transfer 
reactions.  Two of the  6  colostra tested gave slight  reactions in the  con- 
centrated  form but none reacted in  the  1-10 dilution.  The  2 samples of 
colostrum which  reacted  were from mothers  whose own  sera in  dilutions 
of 1-100 to  1-1000 reacted  to the  same antigen. 
Seven of the infants  at ages of 3 to 6 months were tested directly with 
extracts containing  100 or 1000 units of the allergen to which the mother's 
1 1 protein  nitrogen unit  =  0.00001 rag. protein  nitrogen.  Hereafter in this pres- 
entation "unit" refers to protein nitrogen unit. TABLE  I 
Titration ~ Skin-Sensitizing  A ntibodies ~ Maternal, Cord, and Infant Sera and Colostrum 
Cases and 
age 
3hl. 
27 yrs. 
Ean. 
35 yrs. 
~.ro. 
29 yrs. 
[ga. 
29 yrs. 
Emn. 
25 yrs. 
#.dz. 
30 yrs. 
rff. 
27 yrs. 
Lsn. 
24 yrs. 
Sre. 
Diagnoses 
Hay fever, 
asthma 
Asthma 
Hay fever 
Hay fever 
Hay fever, 
vasomotor 
rhinitis 
Hay fever 
Hay fever 
Hay fever 
Hay fever 
Allergen tested 
1000 protein nitro- 
gen units per cc. 
Dilution tests  Infants 
Maternal sera  Cord  Colos-  sera  trum 
Low ragweed  +++  +++  ++  0  0  0 
Cottonseed  ++++  +++  +  0 
Kapok  +++  ++  0  0 
Timothy  +++  ++  +  0 
Low ragweed  +++  ++  +  0 
Timothy  +  ++  ++  +  0 
Low ragweed  ++++  ++++  ++  +  0  0 
Timothy  ++  +  0  0  0 
Dust  ++  ++  +  0  0 
Low ragweed  +++  +++  +++  0  0 
Timothy  +  +  +  0  0  0 
24 yrs. 
Pmd.  Hay fever, 
28 yrs.  va~omotoi 
rhinitis 
Film.  Hay fever 
34 yrs. 
Jpr.  Asthma 
23 yrs. 
Low ragweed  +  +  +  +  0  1  0  0 
Timothy  +  +  +  +  0  [ 0  0 
Low ragweed  +++  +++  ++  0  0 
Timothy  +  -4-  0  0  0 
Wheat  +  0  0  0  0 
Low ragweed  ++++  +++  ++  +  0  0 
Birch  +++  +  0  0  0 
Wheat  -4-  0  0  0  0 
Low ragweed  +  0  0  0  0 
Dust  +  0  0  0  0 
Timothy  +  +  +  +  +  +  0  0 
Plantain  +  +  +  0  0  0 
Sorrel  ++  -4-  0  0  0 
Low ragweed  +  0  0  0  0 
Ash  +  0  0  0  0 
Wheat  +  +  0  0  0 
Dog dander  ++++  +++  ++  0  0 
Horse dander  +  +  +  +  +  +  0  0  0 
Dust  +++  ++  ++  0  0 
513 
0  0 
0  0 
0  0  +  0 
0  0  0  0 
0  0  0 
+  0  0 
0  0  0 
0  0 
0  0 
0  0 
0  0 
0 
0 
0  0 
0  0 
0  0 
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serum reacted in passive transfer, and blood was drawn for passive transfer 
studies.  In  all cases, both the direct tests and  the passive transfer  reac- 
tions were negative  (Table I). 
Placental  Extract.--It has been suggested that  the  skin-sensitizing  anti- 
bodies are intercepted in the cells of the placenta separating maternal  and 
fetal circulation because of the normal affinity of these antibodies for cells. 
On the basis of this theory, an attempt was made to recover skin-sensitiz- 
ing  antibodies from  the placenta.  A  whole placenta (case Aro.)  was per- 
fused with saline until the perfusate was free of blood.  The placenta was 
then ground in a meat grinder and subsequently in a ball mill with a small 
amount of extracting fluid (containing 0.5 per cent NaC1 and 0.35 per cent 
NaHCO3) for 2 hours at 7°C.  The extract was filtered through a Seitz filter 
and  tested in passive transfer  sites as were the  sera.  A  second placenta 
(case Jpr.)  was treated in  the  same manner,  except that  it was extracted 
with  distilled  water  instead  of  the  saline  extracting  fluid.  A  portion  of 
this material was then  frozen with dry ice and  allowed to thaw in an at- 
tempt  to  rupture  cell  membranes.  After  being  filtered  through  a  Seitz 
filter and proved sterile,  the extract was tested by passive transfer as were 
the sera.  Neither the saline extract, nor the water extract, nor the water 
extract of the frozen placenta showed evidence of the skin-sensitizing anti- 
bodies which were demonstrated in the maternal  sera. 
Titration of Blocking  Antibodies 
Seven of the  cord sera were from ragweed hay fever patients  who had 
received  injections  of  pollen  extract  before  the  babies  were  born.  In 
these  sera,  the  presence  of  blocking  antibody  was  tested  by mixing  the 
sera with low ragweed pollen  extract  and  injecting  the mixtures into  the 
skin sites which had been passively sensitized to ragweed.  Table II repre- 
sents a  typical experiment.  Six rows each of six identical  sites were pre- 
pared  by the  intracutaneous  injection  into  each  site  of 0.1  cc.  of a  1-10 
dilution of serum from an untreated case of ragweed hay fever (serum Rr.). 
The serum chosen reacted strongly in passive transfer sites with the fraction 
(fraction  1) of low ragweed pollen extract prepared from whole extract by 
precipitation at pH 4 with 50 per cent ammonium sulfate but reacted only 
slightly with the fraction  (fraction 2) prepared by subsequent precipitation 
with completely saturated ammonium sulfate at the same pH (18).  Other 
experiments have indicated  that  the  blocking  antibody of post treatment 
hay fever sera often inactivates fraction  1 but not fraction  2,  so that  the 
blocking effect of serum on whole low ragweed pollen extract is more appar- 
ent when tested on sites prepared with a  serum reacting mainly to fraction 
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The mixtures for testing were prepared by mixing 0.1  cc.  of each cord 
serum with 0.9  cc.  of low ragweed pollen extract containing 10 units per 
cc.  Three control mixtures were made, 2 with cord sera from mothers who 
were  not  sensitive to  ragweed  and  had  not  received injections of pollen 
extract and one with normal adult serum.  The mixtures were kept over- 
night at 7°C.  and each was then diluted 1-3,  1-9,  1-27,  1-81,  and  1-243. 
The dilutions of each mixture were used to test one row of skin sites. 
The  serum-ragweed mixtures made with the  3  control sera gave  reac- 
tions in higher dilution than the mixtures containing the cord sera of rag- 
weed-treated  mothers.  The  ragweed  in  the  latter  mixtures  had  been 
TABLE  II 
Inactivation of Low Ragweed Extract by Cord or Normal Human Serum 
Thirty skin sites prepared with low ragweed sensitive serum (Rr.) in dilution of 1-10, 
tested 48 hours later with serial dilutions of mixtures of cord or normal human  serum 
with low ragweed extract containing 10 protein nitrogen units per cc. 
Reaction of skin sites 
Dilutions of serum-low  Ean. cord  Wsn. normal 
ragweed mixtures  Lsn. cord serum  Jga. cord serum  Bed. cord serum  +  low ragweed  +  low ragweed  +  low ragweed  serum +  low  serum  +  low  ragweed  ragweed (con- 
(control)  (control)  trod 
Concentrated 
1-3 
1-9 
1-27 
1-81 
1-243 
+++ 
++ 
+ 
+ 
0 
0 
+++ 
++ 
+ 
+ 
0 
0 
+++ 
+++ 
+++ 
++ 
++ 
+ 
+++ 
+++ 
++ 
++ 
++ 
+ 
+++ 
+++ 
+++ 
++ 
++ 
+ 
thus partially inactivated by the blocking antibody contained in the cord 
sera (Table II). 
In such experiments, the  7  cord sera from cases treated with ragweed 
pollen extract were  compared with 2  control cord sera from cases which 
had  not  received  pollen  injections,  with  serum  of  a  normal  untreated 
adult, and with mixtures made with saline instead of serum.  The various 
control mixtures gave  identical results  in  all  comparisons,  showing that 
cord serum from untreated cases did not contain any non-specific inhibit- 
ing agent.  All 7 cord sera from treated mothers when compared with the 
control  sera  showed  evidence of  inactivation of  ragweed  pollen  extract. 
Since  different test  subjects  show  slight  variation  in  reactivity of  skin 
sites, the reactions of the serum tested must be compared with the control 
serum tested simultaneously in the same test subject. 
These 7 cord sera were also compared with the corresponding maternal 
sera  in  similar  experiments.  Since  the  maternal  sera  contained  skin- 616  PLACENTAL  TRANSMISSION" OF ANTIBODIES IN ALLERGY 
sensitizing  antibodies,  they  were heated  for  4  hours  at  56°C.  in  order  to 
destroy this activity.  The cord and control sera were also heated so as to 
maintain  comparable conditions.  It is apparent that this heating  did not 
TABLE  III 
Inactivation of Low Ragweed Extract by Heated Cord and Maternal Sera 
Thirty-six skin sites prepared with low ragweed sensitive serum (Rr.) in dilution of 
1-10, tested 48 hours later with serial dilutions of mixtures of heated cord or maternal 
sera with low ragweed extract containing 10 protein nitrogen units per cc. 
Dilutions of serum-low 
ragweed mixtures 
Concentrated 
1-3 
1-9 
1-27 
1-81 
1-243 
Ghl. cord 
serum +  low 
ragweed 
Ghl. maternal 
serum +  low 
ragweed 
Reaction of skin sites 
Aro. cord  Aro. maternal 
serum -}- low  serum -[- low 
ragweed  ragweed 
o  o 
o  o 
o  o 
o  o 
o  o 
o  o 
Bed. cord 
serum +  low 
ragweed 
(control) 
++ 
++ 
++ 
++ 
+ 
0 
Bed. mater- 
nal serum + 
[ low ragweed 
(control) 
++ 
++ 
++ 
++ 
+ 
0 
TABLE  IV 
Inactivation of Low Ragweed Extract by Infant or Cord Sera 
Thirty skin sites prepared with low  ragweed sensitive serum (Rr.)  in  dilutions  of 
1-10, tested 48 hours later with serial dilutions of mixtures of infant or cord serum with 
low ragweed extract containing 10 protein nitrogen units per cc. 
Dilutions of serum-low 
ragweed mixtures 
Concentrated 
1-3 
1-9 
1-27 
1-81 
1-243 
Reaction of skin sites 
Lsn. infant 
serum +  low 
ragweed 
+++ 
+++ 
++ 
++ 
+ 
+ 
I  Lsn. cord 
serum +  low 
l  ragweed 
+++ 
+++ 
++ 
++ 
+ 
0 
Adz. infant 
serum +  low 
ragweed 
+++ 
+++ 
++ 
++ 
+ 
-4- 
Adz. cord 
serum +  low 
ragweed 
+ 
+ 
o 
o 
o 
o 
Bed. cord seru~ 
-[- low ragweed 
(control) 
+++ 
+++ 
+++ 
++ 
++ 
+ 
materially  affect the  blocking  activity  of the  cord  sera.  All  heated  ma- 
ternal  sera  failed  to  sensitize  normal  skin.  Table  III  shows  typical  re- 
sults.  The  cord  sera  used  in  this  experiment  showed  more  blocking 
activity than  those used in Table II, so that  the ragweed was completely 
inactivated  in  the  strength  used.  In  every  case  the  corresponding  cord 
and  maternal  sera  showed  roughly  comparable blocking  activity.  Exact W.  B.  SHERMAN~  S.  F.  HAMPTON,  AND  R.  A.  COOKE  617 
quantitative comparisons could not be made, as in most of the cases several 
weeks elapsed between the drawing of the maternal and cord bloods.  Some 
of the mothers received additional injections during this interval,  others 
allowed the treatment to lapse. 
Three of the infants' sera taken at 3 to 6 months of age were studied for 
the presence of blocking antibody.  In  Table  IV,  2  of these infant  sera 
are compared with the corresponding cord sera and the same control cord 
serum used in the previous experiment.  This experiment shows that the 
blocking antibody had practically disappeared within 3  to  6  months, al- 
though in  one  case  (Adz.)  the  corresponding cord  serum showed a large 
amount  of  antibody.  The  third  infant  serum,  not  represented  in  the 
table,  showed no evidence of any immune antibody, although the corre- 
sponding cord serum did. 
Titration of Other Antibodies 
For  comparison with  the  skin-sensitizing  and blocking  antibodies,  the 
placental  transmission  of  certain  other  antibodies  present  in  the  same 
maternal sera was studied. 
Hemagglutinins.--The  hemagglutinin  content  of  maternal,  cord,  and 
infant  sera was  determined in  the manner similar  to  that  suggested by 
Wiener  (4).  0.2  cc.  of progressively doubled dilutions  of the  sera were 
mixed with equal volumes of a  2{ per cent suspension of known type A 
and also with known type B  human blood cells.  The mixtures were in- 
cubated  at  37°C.  for  2  hours  and  read by macroscopic and microscopic 
examination.  Interpretations  were recorded "positive"  to  the last  dilu- 
tion  showing  any  degree  of  agglutination  by  microscopic  examination. 
Table V  shows the results of titration of the hemagglutinin content of 
11 maternal, 10 cord, and 6 infant sera.  Four of the 10 cord sera showed 
hemagglutinins,  although  it  has  been  shown  that  none of the  cord  sera 
possessed any skin-sensitizing antibodies.  The ratio of cord serum hemag- 
glutinins  to  maternal  serum  hemagglutinins  ranged  between  2  and  32 
in the four instances where cord hemagglutinins were present and studied 
in dilutions. 
Shick  Test.--Schick  tests were performed on the mothers during preg- 
nancy and upon  6 of the infants at ages 3  to  6 months, using the toxin 
obtained from the New York City Board of Health.  Each infant reacted 
with the same result  (negative or positive)  as  the corresponding mother 
(Table  VI). 
Typhoid  Agglutinins.--In  one  case,  the mother had  received three in- 
jections of triple typhoid vaccine 3 months prior to delivery,  The maternal TABLE  V 
Titration of Hemagglutinins in Maternal and Cord Sera 
Case  Antigen 
Ghl.  A cens 
B  cells 
Ean.  A cells 
B cells 
Aro.  A cells 
B cells 
Jga.  A cells 
B cells 
Emn.  A cells 
B cells 
Adz.  A cells 
B cells 
Ttf.  A cells 
B cells 
Lsn.  A cells 
B cells 
Sre.  A cells 
B cells 
Prod.  A cells 
B cells 
Jpr.  A cells 
B cells 
Dilution 
where ma- 
ternal sera 
were still 
positive 
1-32 
1-8 
1-16 
1-512 
1-64 
1-32 
1-256 
1-128 
1-8 
1-16 
1-4 
1-8 
1-1024 
1-32 
1-64 
Re; ,ct 
~f 
cor t s 
0 
0 
+ 
0 
0 
0 
0 
0 
0 
+ 
+ 
0 
0 
+ 
+ 
0 
0 
0 
0 
on  Dilution of 
~ra  cord sera 
1-2 
1-8 
1-4 
1-4 
q.n.s.* 
Re I~:tion 
of i Lfants' 
era 
0 
0 
+ 
+ 
+ 
+ 
0 
0 
+ 
+ 
Dilution 
where 
infant sera 
were still 
positive 
1-2 
1-4 
14 
1-8 
1-16 
1-16 
* q.n.s.  =  quantity not sufficient. 
TABLE  VI 
Results of Schick Testing on Mothers and Infants 
Case  Mother  Infant  Age of infant 
Jga. 
Emn. 
Lan. 
Pmd. 
Jpr. 
Adz. 
0 
0 
+ 
0 
+ 
0 
0 
0 
+ 
0 
+ 
0 
3  mos. 
3 mos. 
6 mos. 
5  mos. 
3 mos. 
6 mos. 
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and  cord  sera each  agglutinated  a  suspension  of formalized typhoid or- 
ganisms at a  dilution of 1-100.  The infant serum, however, taken at  3 
months,  failed  to  show  agglutinins.  This  finding is  in  accordance with 
previous investigations. 
DISCUSSION 
The findings support those of Bell and Erickkson, in that the naturally 
occurring skin-sensitizing antibodies of human allergy are not transmitted 
through the human placenta.  It was impossible by quantitative dilution 
tests  to establish an index of permeability of  the placenta to these anti- 
bodies such as was suggested  by Wiener  and Silverman  (4).  In this study, 
even when skin-sensitizing antibodies were demonstrated in the maternal 
sera when diluted I00 or  1000 times, the  same antibodies could not be 
demonstrated in the corresponding  undiluted cord sera. 
Four of the 10 cord  sera studied  contained hemagglutinins  and 4 infants 
and their mothers showed  negative reactions by the Schick  test (indicating 
immunity or placental permeability for diphtheria antibody) yet the cord 
sera of these same cases did not show skin-sensitizing antibodies. 
The  demonstration that  cord serum  of  hay fever patients, who  had 
received injections of ragweed pollen extract,  inactivates the  pollen ex- 
tract but does not sensitize normal skin is further evidence of coexistence 
of two distinct antibodies for ragweed  pollen in the blood of treated cases. 
It might be supposed that the presence  of blocking  antibody in the cord 
serum was due to active  immunization of the fetus by pollen antigen pass- 
ing through the placenta and not to transmission of blocking antibody. 
In all of the eases, the mothers had received injections of ragweed pollen 
extract  during pregnancy. There  is  no  direct evidence concerning the 
passage of this antigen through the placenta or of the ability of the fetus 
to form  blocking antibody, but Cooke, Loveless, and Stull (20) have shown 
that such an antibody can be found  in the sera  of non-sensitive  adults who 
received ragweed  pollen injections.  However,  quantitative considerations 
make it seem unlikely  that the blocking antibody in the cord serum was 
produced by the  non-sensitive fetus.  The  normal adults described by 
these authors showed  evidence of blocking antibody only after total doses 
of 200,000 to 1,000,000 units of ragweed  pollen extract, doses  much greater 
than those required  by hay fever patients  sensitive to ragweed; such as, 
the ragweed sensitive mother (case Aro.) who had received a total of only 
4140 units of ragweed  extract, but whose  own serum and the cord  serum of 
her non-sensitive  infant showed  marked blocking antibody.  Furthermore, 
the degree of blocking activity of the maternal and cord  sera in each case 
was as nearly comparable as could be expected  considering  the time in- 620  PLACENTAL  TRANSMISSION  OF  ANTIBODIES  IN  ALLERGY 
terval and further treatment that intervened between  the taking of the 
2 sera.  This was better shown in some of the other cases where the block- 
ing activity of the maternal and cord sera was less than that of the sera 
shown in Table III and in which the ragweed extract was only partially 
inactivated in the range of dilutions used. 
The  disappearance  of  the  blocking  antibody  from  the  infants'  sera 
within 3 to 6 months after birth corresponds with the known facts regarding 
certain antibodies, such as typhoid agglutinin, known to be passively trans- 
mitted to the fetus through the placenta.  The disappearance of blocking 
antibody from the serum of actively immunized hay fever patients is slower. 
For example, the maternal serum (case Aro.) was taken 4 months after the 
last injection of pollen extract,  yet  it  showed active  blocking antibody. 
For all of these reasons, although the possibility of passage of the antigen 
through the placenta cannot be definitely excluded, it seems most probable 
that the fetus acquires the blocking antibody passively and not by active 
immunization. 
The skin-sensitizing antibody which occurs spontaneously in the serum 
of allergic human beings differs from most induced antibodies not only in 
being  thermolabile but  also  in  its  failure  to  pass  through the placenta. 
The blocking antibody, which is developed in response to injections of pollen 
extract,  resembles the antibody produced by injections of other antigens 
in thermostability and in readily passing through the placenta.  The sepa- 
ration of the two antibodies without heating the serum definitely estab- 
lishes that the blocking antibody is not formed from the skin-sensitizing 
antibody by heat. 
The fact that 2 of the 6 colostra showed a  small amount of skin-sensi- 
tizing  antibody suggested that  these antibodies may pass  through some 
cell membranes.  This conflicts with the hypothesis that failure of these 
antibodies to permeate the placenta is due to affinity for cells preventing 
it  from  passing  through  membranes.  The  concentration  of  antibody, 
however, was only one-hundredth to one-thousandth that of the correspond- 
ing maternal sera, and in view of the small volume of colostrum obtainable 
from these women, the actual amount of antibody so secreted must have 
been small. 
SUMMARY 
1.  Quantitative studies of the skin-sensitizing antibodies, blocking anti- 
bodies,  and  hemagglutinins in  sera  of  allergic human beings have  been 
made. 
2.  A comparison of 12 maternal and the 12 corresponding cord sera by W.  B.  SHERMAN~ S.  F.  HAMPTON~ AND  R.  A.  COOKE  621 
the method of passive transfer showed the human placenta to be imperme- 
able to skin-sensitizing  antibodies. 
3.  Direct skin tests and passive transfer studies of 6 infants at the ages of 
3  to  6  months  showed negative  reactions  to  the  antigens  to which  their 
mothers  were  sensitive. 
4.  The blocking antibody present in the sera of hay fever patients after 
treatment with pollen extract injections was also demonstrated in the cord 
sera.  The  apparent  placental  transmission  of this  antibody gave further 
evidence  that  it was distinct  from  the  skin-sensitizing  antibody.  Infant 
sera obtained  at  the  ages of 3  to  6  months  showed  no  evidence  of  this 
immune  antibody. 
5.  The  cord sera from 4 of these cases were shown to contain the same 
isoagglutinins  as  the  maternal  sera,  showing  that  the  placentas  were 
permeable  to  these  antibodies.  The  mothers  and  their  offspring  reacted 
alike  to  Schick testing. 
6.  Typhoid  agglutinins  were  demonstrated  in  maternal  and  cord  sera 
of  an  adult who previously received injections of triple  typhoid  vaccine, 
whereas the  serum of  the  corresponding  infant  at  the  age  of  3  months 
failed to  show  agglutinins. 
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